|
Below are nine pending securities class action lawsuits pending throughout the country in which the deadline for seeking lead plaintiff has not passed. Read on for a brief summary of each case along with the deadline for filling a lead plaintiff motion. If you have any questions, contact Timothy L. Miles at 855-846-6529 or email [email protected] or by submitting you information here. Abbott Laboratories Class Action Lawsuit - (NYSE: ABT)The Abbott Laboratories class action lawsuit seeks to represent purchasers or acquirers of Abbott Laboratories (NYSE: ABT) common stock between February 19, 2021 to June 8, 2022, inclusive (the “Class Period”). If you suffered losses in Abbott Laboratories stock and have questions, please contact Abbott Laboratories Stock Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the Abbott Laboratories class action lawsuit must be filed with the court no later than October 31, 2022. Humanigen, Inc. Class Action Lawsuit – (NASDAQ: HGEN)The Humanigen class action lawsuit seeks to represent purchasers or acquirers of Humanigen, Inc. (NASDAQ: HGEN) securities between May 28, 2021 and July 12, 2022, inclusive (the “Class Period”). If you suffered losses in Humanigen stock and have questions, please contact Humanigen Stock Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the Humanigen class action lawsuit must be filed with the court no later than October 25, 2022. Carvana Co. Class Action Lawsuit - (NYSE: CVNA)The Carvana class action lawsuit seeks to represent purchasers or acquirers of Carvana Co. (NYSE: CVNA) publicly traded securities between May 6, 2020 and June 24, 2022, inclusive (the “Class Period”). If you suffered losses in Carvana stock and have questions, please contact Carvana Stock Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the Carvana class action lawsuit must be filed with the court no later than October 3, 2022 Kiromic BioPharma, Inc. Class Action Lawsuit – (NASDAQ: KRBP)The Kiromic BioPharma class action lawsuit seeks to represent purchasers or acquirers of Kiromic BioPharma, Inc. (NASDAQ: KRBP): (a) common stock pursuant to the registration statement filed and a final prospectus (together, the “Offering Documents”) issued in connection with Kiromic BioPharma’s public offering that closed on July 2, 2021 (the “Offering”); and/or (b) common stock between June 25, 2021 and August 13, 2021, inclusive (the “Class Period”). If you suffered losses in Kiromic BioPharma stock and have questions, please contact Kiromic BioPharma Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the Kiromic BioPharma class action lawsuit must be filed with the court no later than October 4, 2022. Coinbase Global, Inc. Class Action Lawsuit - (NASDAQ: COIN)The Coinbase class action lawsuit seeks to represent purchasers or acquirers of Coinbase Global, Inc. (NASDAQ: COIN) securities between April 14, 2021 and July 26, 2022, inclusive (the “Class Period”). If you suffered losses in Coinbase stock and have questions, please contact Coinbase Stock Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the Coinbase class action lawsuit must be filed with the court no later than October 3, 2022. LifeStance Health Group, Inc. Class Action Lawsuit – (NASDAQ: LFST)The LifeStance Health class action lawsuit seeks to represent purchasers of LifeStance Health Group, Inc. (NASDAQ: LFST) common stock issued in connection with LifeStance Health’s June 10, 2021 initial public stock offering (the “IPO”). If you suffered losses in LifeStance Healthstock and have questions, please contact LifeStance Health Stock Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the LifeStance Health class action lawsuit must be filed with the court no later than October 11, 2022. Contact Co-Diagnostics Stock Loss Lawyer Timothy L. Miles today. Co-Diagnostics Inc. Class Action Lawsuit – (NASDAQ: CODX)The Co-Diagnostics class action lawsuit seeks to represent purchasers of Co-Diagnostics, Inc. (NASDAQ: CODX) publicly traded securities between May 12, 2022 and the close of the market on August 11, 2022 (4:00 p.m. ET), inclusive (the “Class Period”). If you suffered losses in Co-Diagnostics stock and have questions, please contact Co-Diagnostics Stock Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the Co-Diagnostics class action lawsuit must be filed with the court no later than October 17, 2022. Ampio Pharmaceuticals, Inc. Class Action Lawsuit - (NYSEAMERICAN: AMPE)The Ampio class action lawsuit seeks to represent purchasers or acquirers of Ampio Pharmaceuticals, Inc. (NYSEAMERICAN: AMPE) common stock between December 29, 2020 and August 3, 2022, inclusive (the “Class Period”). If you suffered losses in Ampio stock and have questions, please contact Ampio Stock Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the Ampio class action lawsuit must be filed with the court no later than October 17, 2022. Uber Technologies, Inc. Class Action Lawsuit - (NYSE: UBER)The Uber class action lawsuit seeks to represent purchasers or acquirers of Uber Technologies, Inc. (NYSE: UBER) common stock between May 31, 2019 and July 8, 2022, inclusive (the “Class Period”). If you suffered losses in Uber stock and have questions, please contact Uber Stock Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the Uber class action lawsuit must be filed with the court no later than October 17, 2022. TG Therapeutics, Inc. Class Action Lawsuit - (NASDAQ: TGTX)The TG Therapeutics class action lawsuit seeks to represent purchasers or acquirers of TG Therapeutics, Inc. (NASDAQ: TGTX) securities between January 15, 2020 and May 31, 2022, inclusive (the “Class Period”). If you suffered losses in TG Therapeutics stock and have questions, please contact TG Therapeutics Stock Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the TG Therapeutics class action lawsuit must be filed with the court no later than September 16, 2022. 17 Education & Technology Group Inc. Class Action Lawsuit - (NASDAQ: YQ)The 17 Education & Technology class action lawsuit seeks to represent purchasers or acquirers of 17 Education & Technology Group Inc. (NASDAQ: YQ) publicly traded securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with 17 Education & Technology’s December 4, 2020 initial public offering (the “IPO”). If you suffered losses in 17 Education & Technology stock and have questions, please contact 17 Education & Technology Stock Loss Lawyer Timothy L. Miles today. Lead plaintiff motions for the 17 Education & Technology class action lawsuit must be filed with the court no later than September 29, 2022. ConclusionIf you have any questions regarding any of the above cases or lead plaintiff deadlines, contact Timothy L. Miles at 855-846-6529 or email [email protected] or by submitting you information here. Timothy L. Miles, Esq.A TG Therapeutics Stock Loss Lawyer is well-versed in the complex laws that govern the securities industry and litigation. A TG Therapeutics Stock Loss Lawyer focuses on representing individual investors or funds who have been the victims of fraud or who have disputes with investment professionals. Ordinary individual investors, including civil servants, teachers, nurses, and retirees, may need a securities lawyer. In most cases, if they have lost money due to mistakes, incompetence, or fraud by an investment professional. While FINRA, the SEC, and state securities regulators serve a vital role in protecting investors, they simply have too many individuals, firms, and market transactions to monitor to discovery every act of fraud or negligence. Individual investors should consult with a securities lawyer if they have lost money due to fraud or stockbroker misconduct, such as a TG Therapeutics Stock Loss Lawyer who will work to recover the losses you sustained through a TG Therapeutics Class Action lawsuit. Comments are closed.
|
AuthorTimothy L. Miles Archives
December 2024
Categories
All
|
HoursSITEMAP
|
|
